$ICU @SeaStarMedical QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients https://t.co/9NNAbU9Vry by @DavidBautz
$YOUL: First-half revenue topped RMB1.9B, up 100%+ YoY, per the company. Youlife Group CSO Stanley Yang breaks down what drove it and the organic growth outlook from here: https://t.co/d5NCLLQWwc
#ChinaStocks#SmallCaps#Staffing
No Botox biosimilar has been approved since Botox launched in 1989. $AEON is developing ABP-450 to change that, with FDA studies expected in 2027. Our take in 60 seconds: https://t.co/T0U6eqayFX
#biotech#smallcapstocks#biosimilars
Get updates on small caps like $POET, $HOVR, and $GRRR directly to your inbox. Subscribe to Zacks SCR’s complimentary daily, weekly, or new coverage alerts: https://t.co/1sqqasBOkc
#SmallCaps#MicroCaps#EquityResearch#Investing
$MRDN Growth examples include recent acquisition of Fairbet in Malta & sponsorship and also Expanse Studios’ strategic distribution agreement in Serbia #AI#igaming#softwaresolutions#technology https://t.co/CICRorhGou
$GMEX: 87% of hotels reported staffing shortages in 2025, per the AHLA. @GMEXRobotics is building AI robots aimed at that gap, starting in commercial kitchens: https://t.co/vwECDHGIcR
#Robotics#PhysicalAI#SmallCaps